NFKB1 and inflammatory bowel disease: Accordingly, a novel inhibitor of inflammation and oxidation called pyrrolidine dithiocarbamate is demonstrated to be effective on improving IBD symptoms by upregulating GPX4 (83–85), which inversely suppressed NF-κB signaling (119).